Editas Medicine Inc — Quarterly Financial Data (NASDAQ:EDIT) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Editas Medicine Inc

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Новости

Editas (EDIT) Down 8.3% Since Last Earnings Report: Can It Rebound?

NVO Stock Down as Rybelsus Misses Goals in 2 Alzheimer's Studies

Biogen Inks Research Deal With Dayra to Boost Immunology Pipeline

AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo

COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know

Top 3 Genomics Stocks to Consider for Your Portfolio

Is Alto Neuroscience, Inc. (ANRO) Outperforming Other Medical Stocks This Year?

Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y

Clear Street повышает целевую цену акций Editas Medicine до $4,60

Clear Street raises Editas Medicine stock price target to $4.60 on extended cash runway

Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates

Editas Medicine: доходы, прибыль побили прогнозы в Q3